- Home
- IXHL vs CLGN Comparison
IXHL vs CLGN Comparison
Compare IXHL & CLGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IXHL
- CLGN
- Stock Information
- Founded
- IXHL 2001
- CLGN 2004
- Country
- IXHL Australia
- CLGN Israel
- Employees
- IXHL N/A
- CLGN N/A
- Industry
- IXHL
- CLGN Industrial Specialties
- Sector
- IXHL
- CLGN Health Care
- Exchange
- IXHL Nasdaq
- CLGN Nasdaq
- Market Cap
- IXHL 39.2M
- CLGN 46.2M
- IPO Year
- IXHL N/A
- CLGN N/A
- Fundamental
- Price
- IXHL $1.61
- CLGN $3.47
- Analyst Decision
- IXHL
- CLGN Strong Buy
- Analyst Count
- IXHL 0
- CLGN 2
- Target Price
- IXHL N/A
- CLGN $12.50
- AVG Volume (30 Days)
- IXHL 50.6K
- CLGN 5.1K
- Earning Date
- IXHL 02-14-2025
- CLGN 04-03-2025
- Dividend Yield
- IXHL N/A
- CLGN N/A
- EPS Growth
- IXHL N/A
- CLGN N/A
- EPS
- IXHL N/A
- CLGN N/A
- Revenue
- IXHL $98,000.00
- CLGN $650,000.00
- Revenue This Year
- IXHL $3,817.06
- CLGN N/A
- Revenue Next Year
- IXHL $66.67
- CLGN $692.59
- P/E Ratio
- IXHL N/A
- CLGN N/A
- Revenue Growth
- IXHL N/A
- CLGN N/A
- 52 Week Low
- IXHL $1.50
- CLGN $3.24
- 52 Week High
- IXHL $8.47
- CLGN $6.75
- Technical
- Relative Strength Index (RSI)
- IXHL 40.02
- CLGN 36.66
- Support Level
- IXHL $1.54
- CLGN $3.52
- Resistance Level
- IXHL $1.88
- CLGN $3.70
- Average True Range (ATR)
- IXHL 0.15
- CLGN 0.16
- MACD
- IXHL -0.03
- CLGN -0.02
- Stochastic Oscillator
- IXHL 9.99
- CLGN 3.64
About IXHL Incannex Healthcare Inc.
Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products. The Company operates and manages its business as one reportable and operating segment, which is the Research and Development of the use of psychedelic medicine and therapies.
About CLGN CollPlant Biotechnologies Ltd
CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing. The company operates in United States, which derives key revenue, Canada, Europe and Other, and Israel.